Polymeric percutaneous drug penetration enhancer - Synthesis and enhancing property of PEG/PDMS block copolymer with a cationic end group

被引:25
作者
Akimoto, T [1 ]
Aoyagi, T [1 ]
Minoshima, J [1 ]
Nagase, Y [1 ]
机构
[1] Sagami Chem Res Ctr, Kanagawa 229, Japan
关键词
transdermal penetration; penetration enhancer; polydimethylsiloxane; poly(ethylene glycol); block copolymer; cationic end group;
D O I
10.1016/S0168-3659(97)00092-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poly(ethylene glycol)/polydimethylsiloxane (PEG/PDMS) block copolymers containing an ammonium moiety at one chain end with various molecular weights were prepared to develop a silicone-based polymeric transdermal penetration enhancer. As the precursor of the desired block copolymer, 3-chloropropyl-terminated PEG/PDMS block copolymers were prepared via an initiator method, i.e. the anionic ring-opening polymerization of hexamethylcyclotrisiloxane was carried out by initiating with silanolate anion derived from PEG-silanol, alpha-3-(dimethylhydroxysilyl)propyl-omega-methyl-PEG oligomer. The initiator, PEG-silanol, was obtained from alpha-allyl-PEG by hydrosilylation with dimethylethoxysilane, followed by hydrolysis of the ethoxysilyl group. The enhancing activity in the drug penetration was evaluated by in vitro experiments using a two-chamber diffusion cell. Indomethacin and antipyrine were used as hydrophobic and hydrophilic model drugs, respectively, and the amounts of drugs permeating through the rabbit abdominal skin were measured with or without these polymeric enhancers. These enhancers were very effective for the penetration of hydrophilic drug, but not for that of hydrophobic one. On the other hand, the enhancing activities were influenced by the chain length of PDMS and PEG components. A suitable balance between the hydrophobic PDMS segment and the hydrophilic PEG segment would exist for a high enhancing activity of drug penetration. It was also found that the enhancing activity was due to an increase of the partition coefficient of a drug into the stratum corneum, from the determination of kinetic parameters in the drug permeation. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:229 / 241
页数:13
相关论文
共 17 条
[1]   POLYMERIZATION OF BENZALKONIUM CHLORIDE-TYPE MONOMER AND APPLICATION TO PERCUTANEOUS DRUG ABSORPTION ENHANCER [J].
AOYAGI, T ;
TERASHIMA, O ;
SUZUKI, N ;
MATSUI, K ;
YU, NG .
JOURNAL OF CONTROLLED RELEASE, 1990, 13 (01) :63-71
[2]   PREPARATION OF A POLYMER CONTAINING HEXADECYLPYRIDINIUM BROMIDE GROUPS AND ITS UTILIZATION AS A TRANSDERMAL DRUG PENETRATION ENHANCER [J].
AOYAGI, T ;
TERASHIMA, O ;
NAGASE, Y ;
MATSUI, K .
POLYMER, 1991, 32 (11) :2106-2111
[3]   Novel silicones for transdermal therapeutic system .6. Preparation of oligodimethylsiloxane containing 2-pyrrolidone moiety as a terminal group and its enhancing effect on transdermal drug penetration [J].
Aoyagi, T ;
Tadenuma, R ;
Nagase, Y .
MACROMOLECULAR CHEMISTRY AND PHYSICS, 1996, 197 (02) :677-686
[4]   NOVEL SILICONES FOR TRANSDERMAL THERAPEUTIC SYSTEMS .1. SYNTHESIS OF 1-METHYL-4-PYRIDINIO-TERMINATED POLYDIMETHYLSILOXANE AND EVALUATION AS A TRANSDERMAL PENETRATION ENHANCER [J].
AOYAGI, T ;
TAKAMURA, Y ;
NAKAMURA, T ;
YABUCHI, Y ;
NAGASE, Y .
POLYMER, 1992, 33 (10) :2203-2207
[5]   NOVEL SILICONES FOR TRANSDERMAL THERAPEUTIC SYSTEM .2. PREPARATION OF OLIGODIMETHYLSILOXANES CONTAINING DIETHYL PHOSPHORAMIDATE GROUP AT THE CHAIN END AND THE EVALUATION AS TRANSDERMAL PENETRATION ENHANCERS [J].
AOYAGI, T ;
NAKAMURA, T ;
NAGASE, Y .
POLYMER JOURNAL, 1992, 24 (04) :375-381
[6]   NOVEL SILICONES FOR TRANSDERMAL THERAPEUTIC SYSTEM .3. PREPARATION OF PYRIDINIO-TERMINATED OR AMMONIO-TERMINATED POLYDIMETHYLSILOXANES AND THE EVALUATION AS TRANSDERMAL PENETRATION ENHANCERS [J].
AOYAGI, T ;
NAKAMURA, T ;
YABUCHI, Y ;
NAGASE, Y .
POLYMER JOURNAL, 1992, 24 (06) :545-553
[7]  
ASHTON P, 1986, PHARM ACTA HELV, V61, P228
[8]  
Braybrook J H, 1990, Drug Des Deliv, V6, P73
[9]  
BUDAVARI S, 1996, MERCK INDEX, P4995
[10]   EFFECT OF D-LIMONENE ON THE TRANSDERMAL PERMEATION OF NIFEDIPINE AND DOMPERIDONE [J].
CALPENA, AC ;
LAUROBA, J ;
SURIOL, M ;
OBACH, R ;
DOMENECH, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 103 (02) :179-186